SUSD3: A Potential Drug Target and Biomarker for Sushi-Inspired Neurodegenerative Disorders

Target Name: SUSD3

NCBI ID: G203328

SUSD3: A Potential Drug Target and Biomarker for Sushi-Inspired Neurodegenerative Disorders

Sushi, a traditional Japanese dish made from raw fish and vegetables, has become a global phenomenon in recent years due to its unique flavor, taste, and cultural significance. However, sushi consumption has also been linked to an increased risk of various neurological and psychiatric disorders, including neurodegenerative diseases. The high levels of mercury found in some sushi samples have been reported to cause cognitive and behavioral problems in humans, including memory loss, anxiety, and depression.

One of the primary objectives of this article is to identify SUSD3, a protein that is expressed in the brain and has been shown to be involved in the development of neurodegenerative diseases. We will explore the potential implications of SUSD3 as a drug target and biomarker for these disorders.

SUSD3: Structure and Function

SUSD3 is a protein that is encoded by the gene DSPP (DNA-sensitive RNA polymerase), which is located on chromosome 11p16. It is a 21-kDa protein that contains a N-terminal transmembrane domain, a coiled-coil region, and a C-terminal T-loop domain. SUSD3 functions as a RNA polymerase, which is responsible for transcribing DNA into RNA.

SUSD3 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

SUSD3 and Neurodegenerative Diseases

SUSD3 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by the progressive loss of brain cells, which can result in a range of symptoms, including cognitive decline, behavioral changes, and neurodegeneration.

Studies have shown that SUSD3 is expressed in the brains of individuals with neurodegenerative diseases, and that it is involved in the development and progression of these disorders. For example, a study by Kim et al. (2018) found that SUSD3 was expressed in the brains of individuals with Alzheimer's disease and that it was associated with the development of these disorders.

In addition, SUSD3 has also been shown to be involved in the pathophysiology of various neurodegenerative diseases. For example, a study by Zhang et al. (2019) found that SUSD3 was expressed in the brains of individuals with Parkinson's disease and that it was associated with the development of these disorders.

Potential Drug Target and Biomarker

The high levels of mercury found in some sushi samples have been reported to cause cognitive and behavioral problems in humans, including memory loss, anxiety, and depression. SUSD3 has been shown to be involved in the development and progression of neurodegenerative diseases, making it a potential drug target and biomarker for these disorders.

SUSD3 can be targeted by small molecules, such as those that can inhibit its activity as a RNA polymerase. This would result in the translation of RNA into protein, which could potentially lead to the inhibition of SUSD3-mediated neurodegeneration.

In addition, SUSD3 can also be used as a biomarker for neurodegenerative diseases. The levels of SUSD3 have been shown to be involved in the development and progression of various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This suggests that SUSD3 may be a useful biomarker for the diagnosis and

Protein Name: Sushi Domain Containing 3

Functions: May play a role in breast tumorigenesis by promoting estrogen-dependent cell proliferation, cell-cell interactions and migration

More Common Targets